Inflammatory responses of tissue-engineered xenografts in a clinical scenario

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 3, 2011, Pages 360-365

  Mathapati, Santosh ^a,b   Verma, Rama Shanker ^b   Cherian, Kotturathu Mammen ^a   Guhathakurta, Soma ^a  

^a Dr KM Cherian Heart Foundation   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Acellular tissue engineered valved conduit; Bioprosthetic heart valves; Carbohydrate antigen; Decellularisation; Immune response

Indexed keywords

CARBOHYDRATE ANTIGEN; COLLAGEN; GALACTOSE; IMMUNOGLOBULIN M; T ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ANTIGEN FUNCTION; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART VALVE BIOPROSTHESIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REACTION; VASCULARIZATION; XENOGRAFT;

ALPHA-GALACTOSIDASE; ANIMALS; ANTIBODIES; ANTIGENS, VIRAL, TUMOR; BIOPROSTHESIS; CATTLE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFANT; INFLAMMATION; JUGULAR VEINS; PROSTHESIS DESIGN; PULMONARY ARTERY; SWINE; TIME FACTORS; TISSUE ENGINEERING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952328000     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.256719     Document Type: Article

References (15)

1. Zilla P, Brink J, Human P, Bezuidenhout D. Prosthetic heart valves: catering for the few. Biomaterials 2008;29:385-406.
2. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79:1072-1080.
3. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007;7:519-531.
4. Kirkeby S, Mikkelsen HB. Distribution of the a-Gal and the non a-Gal T-antigens in the pig kidney: potential targets for rejection in pig-to-man xenotransplantation. Immunol Cell Biol 2008;86:363-371.
5. Guhathakurta S, Varghese S, Balasubramanian V, Agarwal R, Murthy BS, Veerappan S, Padmaja P, Cherian KM. Technique to process xenogenic tissues for cardiovascular implantation - a preliminary report. Curr Sci 2006;91:1068-1073.
6. Guhathakurta S, Balasubramanian V, Ananthakrishnan B, Veerappan S, Balasundari R, Tata BVR, Cherian KM. Thrombogenicity studies of three different variants of tissue engineered bovine pericardium. IRBM 2008; 29:223-230.
7. Katopodis AG, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A, Kretz O, Dorobek B, Persohn E, Andres H, Schweitzer A, Thoma G, Kinzy W, Quesniaux VF, Cozzi E, Davies HF, Mañez R, White D. Removal of anti-Gala1,3Gal xenoantibodies with an injectable polymer. J Clin Invest 2002;110:1869-1877.
8. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg 2001;71:S428-S432.
9. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue engineered heart valve. Ann Thorac Surg 2002;74:1438-1442.
10. Sayk F, Bos I, Schubert U, Wedel T, Sievers HH. Histopathologic findings in a novel decellularized pulmonary homograft: an autopsy study. Ann Thorac Surg 2005;79:1755-1758.
11. Gong G, Seifter E, Lyman W, Factor S, Blau S, Frater R. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions. J Heart Valve Dis 1993;2:684-693.
12. Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009;8:457-470.
13. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003; 23:1002-1006.
14. Ansaloni L, Cambrini P, Catena F, Di Saverio S, Gagliardi S, Gazzotti F, Hodde JP, Metzger DW, D'Alessandro L, Pinna AD. Immune response to small intestinal submucosa (surgisis) implant in humans: preliminary observations. J Invest Surg 2007;20:237-241.
15. Xu H, Wan H, Sandor M, Qi S, Ervin F, Harper JR, Silverman RP, McQuillan DJ. Host response to human acellular dermal matrix transplantation in a primate model of abdominal wall repair. Tissue Eng Part A 2008;14:2009-2019.